Ignacio de la Fuente

Risk factors and outcome of COVID-19 in patients with hematological malignancies

José Luís Piñana, Rodrigo Martino, Irene García‐García et al. · Experimental Hematology and Oncology · 2020 · 152 citations · Full text

HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients

Álvaro Tamayo-Velasco, Pedro Martínez-Paz, María Jesús Peñarrubia-Ponce et al. · Journal of Clinical Medicine · 2021 · 49 citations · Full text

Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome

Maribel Forero‐Castro, Cristina Robledo, Rocí­o Benito et al. · PLoS ONE · 2016 · 46 citations · Full text

H-ras Immunohistochemical Expression and Molecular Analysis of Urinary Bladder Lesions in Grazing Adult Cattle Exposed to Bracken Fern

David Sardón, Ignacio de la Fuente, Esther Calonge et al. · Journal of Comparative Pathology · 2005 · 33 citations

Urology, Animal Science, Medicine +4

A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia

Isabel González-Gascón-y-Marín, María Hernández‐Sánchez, Ana‐Eugenia Rodríguez‐Vicente et al. · Hematological Oncology · 2015 · 30 citations